网红黑料

, an internationally known expert in the scientific understanding of Alzheimer鈥檚 disease, has been appointed executive director of the . His appointment will be effective Dec. 1.

鈥淲e are very fortunate to have Dr. Golde lead the McKnight Brain Institute,鈥� said David S. Guzick, M.D., Ph.D., UF senior vice president for health affairs and president of 网红黑料. 鈥淗e is a world-class translational scientist and is committed to promoting collaborative neuroscience among an expanding base of research programs under the institute鈥檚 umbrella. Dr. Golde鈥檚 expertise will also stimulate cross-cutting investigation at the MBI, creating interfaces, for example, between basic, translational and clinical scientists who are supported by the McKnight Brain Research Foundation.鈥�

Golde, currently a professor of neuroscience and director of UF鈥檚 Center for Translational Research in Neurodegenerative Disease and the 1Florida Alzheimer鈥檚 Disease Research Center consortium of institutions, has served the MBI for six years as both an investigator and a leader, pioneering programs to closely link basic-science laboratory work with patient-based studies to translate new discoveries into diagnoses and treatments.

Golde was selected as the new MBI director after an extensive national search. Interim executive director , will continue as deputy director.

鈥淒r. Golde stood out among the candidates as the person with a vision for bringing together the MBI to build on the current research and education programs, taking them to the next level,鈥� said , 网红黑料 executive vice president for research and education and the chair of the MBI director search committee.

Golde came to 网红黑料 from the Mayo Clinic in Jacksonville, bringing a wealth of administrative and strategic-planning experience. As chair of Mayo鈥檚 department of neuroscience, he oversaw an extramural grant portfolio that exceeded $10 million a year.

An investigator into the study of Alzheimer鈥檚 disease for almost three decades, Golde has published more than 220 papers that have been cited more than 25,000 times. He has expanded his leading-edge research to include other neurodegenerative diseases, cancer and even malaria.

鈥淚n this new role, I hope to use these experiences to ensure that our broad neuroscience research and education programs flourish and are viewed as world-class,鈥� Golde said. 鈥淢y passion is to assemble multidisciplinary teams of physicians and scientists to conduct research into neurological disorders that could one day help change the current understanding of many of these diseases from being incurable, inevitable and largely untreatable to a new reality in which these disorders can be cured, prevented and treated.鈥�

Nationally, Golde is a member of the medical and scientific advisory board for the Alzheimer鈥檚 Association and the BrightFocus Foundation. He also serves on several state advisory boards related to Alzheimer鈥檚 disease.

At the MBI, Golde will succeed Tetsuo Ashizawa, M.D., who is now director of the neurosciences research program at Houston Methodist Hospital.

Golde aims to align the vision and mission of the MBI, at a time when UF is preparing to open a new hospital devoted solely to neuromedicine in 2017.

鈥淲e鈥檝e made a lot of investments in neuromedicine and neuroscience research at the 网红黑料 Science Center over the last five years,鈥� he said. 鈥淲e have outstanding investigators, and I want to help them collaborate and find synergy and share resources so we can continue our growth in this area. Moving forward, we鈥檇 like more connections between research at the lab bench and care at the bedside.鈥�